ALTERITY THERAPEUTICS LTD
ALTERITY THERAPEUTICS LTD is a Healthcare company operating in Biotechnology with a $89.4M market cap.
Most recent earnings call: Q2 FY21 on Feb 25, 2021.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks ATHE's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ATHE.
$ curl https://api.spokenalpha.com/v1/companies/ATHEFAQ
Spoken Alpha indexes ATHE's earnings call transcripts at https://spokenalpha.com/companies/ATHE. Each call links to attributed speakers and parsed analyst Q&A.
ALTERITY THERAPEUTICS LTD (ATHE) held its most recent earnings call on 2021-02-25, covering fiscal Q2 2021.
ALTERITY THERAPEUTICS LTD (ATHE) operates in the Healthcare sector (Biotechnology industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2021 | $5.83 | $4.12 | +41.5% | -1.0% | +0.5% |
| Q4 FY2021 | $5.48 | $4.23 | +29.6% | -3.4% | -3.7% |
| Q3 FY2021 | $5.48 | $4.14 | +32.3% | -3.4% | -3.6% |
| Q2 FY2021 | $5.80 | $4.20 | +38.1% | +4.9% | +3.2% |
| Q1 FY2020 | $5.53 | $4.19 | +32.1% | -3.1% | -3.2% |
| Q4 FY2020 |
| $6.06 |
| $4.35 |
| +39.4% |
| +1.6% |
| +1.6% |
| Q3 FY2020 | $5.99 | $4.45 | +34.7% | -0.2% | -0.8% |
| Q2 FY2020 | $5.83 | $4.43 | +31.6% | -0.8% | -0.5% |
| Q1 FY2019 | $5.66 | $4.35 | +30.1% | +2.9% | +3.7% |
| Q4 FY2019 | $5.86 | $4.34 | +35.1% | +0.3% | +0.4% |